Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 23% ± 6% | |
lung | 11 studies | 25% ± 8% | |
intestine | 4 studies | 23% ± 8% | |
placenta | 4 studies | 24% ± 6% | |
brain | 4 studies | 25% ± 4% | |
kidney | 3 studies | 22% ± 4% | |
eye | 3 studies | 18% ± 1% | |
breast | 3 studies | 16% ± 1% | |
liver | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11370.73 | 1445 / 1445 | 100% | 35.88 | 183 / 183 |
liver | 100% | 10202.21 | 226 / 226 | 100% | 50.87 | 406 / 406 |
pancreas | 100% | 8550.18 | 328 / 328 | 100% | 54.67 | 178 / 178 |
skin | 100% | 11909.35 | 1809 / 1809 | 100% | 91.55 | 472 / 472 |
stomach | 100% | 8474.85 | 359 / 359 | 100% | 37.11 | 286 / 286 |
thymus | 100% | 14635.27 | 653 / 653 | 100% | 53.47 | 605 / 605 |
uterus | 100% | 10336.64 | 170 / 170 | 100% | 53.54 | 459 / 459 |
lung | 100% | 16029.86 | 578 / 578 | 100% | 51.07 | 1152 / 1155 |
bladder | 100% | 11726.05 | 21 / 21 | 100% | 76.69 | 502 / 504 |
prostate | 100% | 10939.67 | 245 / 245 | 100% | 45.07 | 500 / 502 |
kidney | 100% | 7767.78 | 89 / 89 | 100% | 53.00 | 897 / 901 |
ovary | 100% | 10025.13 | 180 / 180 | 100% | 40.15 | 428 / 430 |
intestine | 100% | 9620.24 | 966 / 966 | 99% | 39.98 | 523 / 527 |
breast | 100% | 15725.27 | 459 / 459 | 99% | 45.30 | 1108 / 1118 |
adrenal gland | 100% | 8761.64 | 258 / 258 | 99% | 34.07 | 227 / 230 |
brain | 97% | 4004.85 | 2561 / 2642 | 100% | 35.70 | 705 / 705 |
adipose | 100% | 17688.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 98.48 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 99.86 | 29 / 29 |
spleen | 100% | 18939.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.25 | 1 / 1 |
heart | 100% | 7720.97 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10661.49 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 17381.69 | 927 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 4852.15 | 781 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0001701 | Biological process | in utero embryonic development |
GO_0006049 | Biological process | UDP-N-acetylglucosamine catabolic process |
GO_0019082 | Biological process | viral protein processing |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0030145 | Molecular function | manganese ion binding |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0003827 | Molecular function | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MGAT1 |
Protein name | Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (GNT-I) (GlcNAc-T I) (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) |
Synonyms | MGAT GLCT1 GGNT1 GLYT1 |
Description | FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans. . |
Accessions | ENST00000427865.2 D6RB69 ENST00000514438.1 ENST00000506889.1 ENST00000504671.1 D6RA48 D6RHZ8 D6RD15 ENST00000514283.1 ENST00000502678.1 D6RAK2 D6RF69 D6RBS3 D6R9U2 ENST00000446023.6 ENST00000307826.5 ENST00000512695.1 ENST00000333055.8 P26572 ENST00000506269.1 D6RIS2 ENST00000513431.5 ENST00000393340.7 ENST00000507384.1 |